A Chromatin-Mediated Reversible Drug-Tolerant State in Cancer Cell Subpopulations, Cell, vol.141, issue.1, p.69, 2010. ,
DOI : 10.1016/j.cell.2010.02.027
Life history trade-offs in cancer evolution, Nature Reviews Cancer, vol.269, issue.12, p.883, 2013. ,
DOI : 10.1038/nrc3606
Variable Clonal Repopulation Dynamics Influence Chemotherapy Response in Colorectal Cancer, Science, vol.339, issue.6119, p.543, 2013. ,
DOI : 10.1126/science.1227670
Quantitative high-throughput efficacy profiling of approved oncology drugs in inflammatory breast cancer models of acquired drug resistance and re-sensitization, Cancer Letters, vol.337, issue.1, p.77, 2013. ,
DOI : 10.1016/j.canlet.2013.05.017
Tumor Morphology and Phenotypic Evolution Driven by Selective Pressure from the Microenvironment, Cell, vol.127, issue.5, p.905, 2006. ,
DOI : 10.1016/j.cell.2006.09.042
Gene Expression Noise Facilitates Adaptation and Drug Resistance Independently of Mutation, Physical Review Letters, vol.107, issue.21, p.218101, 2011. ,
DOI : 10.1103/PhysRevLett.107.218101
A theoretical quantitative model for evolution of cancer chemotherapy resistance, Biology Direct, vol.5, issue.1, p.25, 2010. ,
DOI : 10.1186/1745-6150-5-25
The Role of Cell Density and Intratumoral Heterogeneity in Multidrug Resistance, Cancer Research, vol.73, issue.24, p.7168, 2013. ,
DOI : 10.1158/0008-5472.CAN-13-1768
Populational adaptive evolution, chemotherapeutic resistance and multiple anti-cancer therapies, ESAIM: Mathematical Modelling and Numerical Analysis, vol.47, issue.2, p.377, 2013. ,
DOI : 10.1051/m2an/2012031
URL : https://hal.archives-ouvertes.fr/hal-00714274
Causes and Consequences of Increased Glucose Metabolism of Cancers, Journal of Nuclear Medicine, vol.49, issue.Suppl_2, p.24, 2008. ,
DOI : 10.2967/jnumed.107.047258
Turning ecology and evolution against cancer, Nature Reviews Cancer, vol.148, issue.5, p.371, 2014. ,
DOI : 10.1038/nature13187
Spontaneous epigenetic variation in the Arabidopsis thaliana methylome, Nature, vol.29, issue.7376, p.245, 2011. ,
DOI : 10.1038/nature10555
Mechanism-Based Epigenetic Chemosensitization Therapy of Diffuse Large B-Cell Lymphoma, Cancer Discovery, vol.3, issue.9, p.1002, 2013. ,
DOI : 10.1158/2159-8290.CD-13-0117
Combination Epigenetic Therapy Has Efficacy in Patients with Refractory Advanced Non-Small Cell Lung Cancer, Cancer Discovery, vol.1, issue.7, p.598, 2011. ,
DOI : 10.1158/2159-8290.CD-11-0214
Cancer as a dysregulated epigenome allowing cellular growth advantage at the expense of the host, Nature Reviews Cancer, vol.101, issue.7, p.497, 2013. ,
DOI : 10.1038/nrc3486